Several antioxidant pathways are involved in astrocyte protection by melatonin

Journal of Pineal Research

Volumn 33, Issue 4, 2002, Pages 204-212

  Martín, Vanesa ^a   Sainz, Rosa M ^a   Antolín, Isaac ^a   Mayo, Juan C ^a   Herrera, Federico ^a   Rodríguez, Carmen ^a,b  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Faculty de Medicina   (Spain)

Author keywords

Astrocytes; Glutathione; Glutathione peroxidase; Melatonin; Oxidative stress

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE; MELATONIN; SCAVENGER;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HORMONE ACTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0036828903     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2002.02113.x     Document Type: Article

References (62)

1. Reiter RJ. The pineal and its hormones in the control of reproduction in mammals. Endocrine Rev 1980; 1:109-131.
2. Reiter RJ. Oxidative damage in the central nervous system, protection by melatonin. Progress Neurobiol 1998; 56:359-384.
3. Mayo JC, Sainz RM, Uria H et al. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells, implications for Parkinson's disease. J Pineal Res 1998; 24:179-192.
4. Tan DX, Chen LD, Poeggeler B et al. Melatonin. a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
5. Barlow-Walden L, Reiter RJ, Abe M et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26:497-502.
6. Antolin I, Rodriguez C, Sainz RM et al. Neurohormone melatonin prevents cell damage, effect on gene expression for antioxidant enzymes. FASEB J 1996; 10:882-890.
7. Pozo D, Reiter RJ, Calvo JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65:430-442.
8. Urata Y, Honma S, Goto S. Melatonin induces gamma- glutamylcysteine synthetase mediated by activator protein-1 in human cells. Free Rad Biol Med 1999; 27:838-847.
9. Pappolla M, Sos M, Omar RA et al. Melatonin prevents death of neuroblastoma cells exposed to Alzheimer's amyloid peptide. J Neurosci 1997; 17:1683-1690.
10. Post A, Holsboer F, Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells, suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci 1998; 18:8236-8246.
11. Acuña-Castroviejo D, Coto-Montes A, Monti G et al. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997; 60:23-29.
12. Ortiz GG, Crespo-Lopez ME, Moran-Moguel C et al. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuroendocrinol Lett 2001; 22:101-108.
13. Dabbeni-Sala F, Di Santo S, Franceschini D et al. Melatonin protects against 6-OHDA-induced neurotoxicity in rats, a role for mitochondrial complex I activity. FASEB J 2001; 15:164-170.
14. Antolin I, Mayo JC, Sainz RM et al. Long term low dose treatment with MPTP causes neuronal death in the substantia nigra of mice, prevention by melatonin. Brain Res 2002; 943:163-173.
15. Pearce RK, Owen A, Daniel S et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm 1997; 104:661-677.
16. Sagara JI, Miura K, Bannai S. Maintenance of neuronal glutathione by glial cells. J Neurochem 1993; 61:1672-1676.
17. Dringen R, Pfeier B, Hamprech B. Synthesis of the anti-oxidant glutathione in neurons, supply by astrocytes of CysGly as a precursor for neuronal glutathione. J Neurosci 1999; 19:562-569.
18. Damier P, Hirsch EC, Zhang P et al. Glutathione peroxidase glial cells and Parkinson's disease. Neuroscience 1993; 52:1-6.
19. Dringen R, Kussmaul L, Gutterer JM et al. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem 1999; 72:2523-2530.
20. Borlongan CV, Yamamoto M, Takel N et al. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J 2000; 14:1307-1317.
21. Chun HS, Gibson GE, Degiorgio LA et al. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanisms. J Neurochem 2001; 76:1010-1021.
22. Halliwell B, Gutteridge JMC. The chemistry of oxygen radicals and other oxygen-derived species. In: Free Radicals in Biology and Medicine. Halliwell B, Gutteridge JMC, eds. Clarendon Press, Oxford, 1985; pp. 20-66.
23. Berman SB, Hastings TG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria, implications for Parkinson's disease. J Neurochem 1999; 73:1127-1137.
24. Langeveld CH, Schepens MP, Jongenelen CAM et al. Presence of glutathione immunoreactivity in cultured neurons and astrocytes. NeuroReport 1996; 7:1833-1836.
25. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. J Immunol Meth 1986; 89:271-277.
26. Decker T, Lohmann-Mattes ML. A quick simple method for the quantification of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Meth 1988; 15:61-69.
27. Floreani M, Petrone M, Debetto P et al. A comparison between different methods for determination of reduced oxidized glutathione in mammalian tissues. Free Radic Res 1997; 26:449-455.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by a guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
29. Ho YS, Crapo JD. cDNA and deduced amino acid sequence of rat copper-zinc-containing superoxide dismutase. Nucleic Acid Res 1987; 15:6746-6754.
30. Ellerby LM, Bredesen DE. Measurement of cellular oxidation, reactive oxygen species, and antioxidant enzymes during apoptosis. Meth Enzymol 2000; 322:413-421.
31. Kotler M, Rodriguez C, Sainz RM et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24:83-89.
32. Bains JS, Shaw CA. Neurodegenerative disorders in humans. the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 1997; 25:335-358.
33. Videla LA. Assessment of the scavenging action of reduced glutathione, (+)-cyanidanol-3 and ethanol by the chemiluminescent response of the xanthine oxidase reaction. Experientia 1983; 39:500-502.
34. CHiu DT, Stults FH, Tappel AL. Purification and properties of rat lung soluble glutathione peroxidase. Biochim Biophys Acta 1976; 445:558-566.
35. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9:526-533.
36. Drukarch B, Schepens E, Jongenelen CAM et al. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res 1997; 770:123-130.
37. Ben-Yoseph O, Boxer PA, Ross BD. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem 1996; 66:2329-2337.
38. Griffith O. Mechanism of action, metabolism and toxicity of buthionine sulfoxamine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 1982; 257:13704-13712.
39. Halliwell B, Gutteridge JMC. Protection against oxygen radicals in biological systems, the superoxide theory of oxygen toxicity. In: Free Radicals in Biology and Medicine. Halliwell B. Gutteridge JMC. eds. Clarendon Press, Oxford, 1985; pp. 67-138.
40. Muller M, Tausz M, Wonisch A et al. Effects of an oxidizing agent (hydrogen peroxide) on the glutathione system in epidermal cells of Allium cepa L. investigated by histochemical staining. Free Radic Res 1999; 31(Suppl):S121-127.
41. Rohrdanz E, Schmuck G, Ohler S et al. Changes in anti- oxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells. Arch Toxicol 2001; 75:150-158.
42. McNaught KP, Jenner P. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures. J Neurochem 1999; 73:2469-2476.
43. Hirsch EC, Hunot S, Damier P et al. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. In: Parkinson's Disease, Advances in Neurology. Stern GM, ed., Lippincott Williams & Wilkins, Philadelphia. 1999: pp. 9-18.
44. Cooper AJ, Kristal BS. Multiple roles of glutathione in the central nervous system. J Biol Chem 1997; 378:793-802.
45. Noack H, Lindenaus J, Rothe F et al. Differential expression of superoxide dismutase isoforms in neuronal and glial compartment in the course of excitotoxically mediated neurode-generation, relation to oxidative and nitrergic stress. Glia 1998; 23:285-297.
46. Lucius R, Sievers J. Postnatal retinal ganglion cells in vitro, protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes. Brain Res 1996; 743:56-62.
47. Desagher S, Glowinski J, Premot J. Astrocytes protects neurons from hydrogen peroxide toxicity. J Neurosci 1996; 16:2553-2562.
48. Tan DX, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in bile of mammals. Life Sci 1999; 65:2523-2529.
49. Kiner DC, Malpeux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140:4399-4405.
50. Reiter RJ, Tan DX. Role of CSF in the transport of melatonin. J Pineal Res 2002; 33:61.
51. Tan DX, Manchester LC, Reiter RJ et al. Identification of highly elevated levels of melatonin in bone marrow: Its origin and significance. Biochim Biophys Acta 1999; 1472:206-214.
52. Martin M, Macias M, Leon J et al. Melatonin increases the, activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 2002; 34:348-357.
53. Stefulj J, Hortner M, Ghosh M et al. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat. J Pineal Res 2001; 30:243-247.
54. Seabra M, Begnitto M, Pinto LR et al. JR Randomized. double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000; 29:193-200.
55. Jan DE, Hamilton D, Seward N et al. CLINICAL trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res 2001; 29:34-39.
56. Hsu CH, Chi BC, Casid JE. Melatonin reduces phosphine-induced lipid and DNA oxidation in vitro and in vivo in rat brain. J Pineal Res 2002; 32:53-58.
57. Shen YX, Xu SJ, Wei W et al. The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25-35 in middle-aged rats. J Pineal Res 2002; 32:85-89.
58. Pappolla MA, Simowich MJ, Bryant-Thomas T et al. The neuroprotective activities of melatonin against the Alzheimer β-protein are not mediated by melatonin membrane receptors. J Pineal Res 2002; 32:135-142.
59. Baydas G, Reiter RJ, Nedzvetskii VS et al. Altered glial fibrillary acidic protein content and its degradation in the hippocampus, cortex and cerebellum of rats exposed to constant light: Reversal by melatonin. J Pineal Res 2002; 33:134-139.
60. Reiter RJ, Melchiorri D, Sewerynek E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11.
61. Matsuo M, Gomi F, Dooley MM. Age-related alterations in antioxidant capacity and lipid peroxidation in brain, liver, and lung homogenates of normal and vitamin C-deficient rats. Mech Ageing Dev 1992; 64:273-292.
62. Youdim KA, Deans SG. Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid comosition of the ageing rut brain. Br J Nutr 2000; 83:87-93.